A local pharmaceutical industry body is questioning why almost half of the main medicines in a three-year R11bn antiretroviral (ARV) tender will be bought from Indian companies while SA’s Adcock Ingram was overlooked.

The tender is awarded by the department of health every three years and covers all the ARV drugs used by the state in the world’s largest HIV treatment programme...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.